KetoSwiss

KetoSwiss is a Swiss biotechnology company focused on developing metabolic therapies for neurological and neurodegenerative diseases. The company's primary focus is on the "energy gap" in the brain, a condition where glucose metabolism is impaired, leading to neurological symptoms such as migraines. Their lead product, MigraKet, is a medical food containing exogenous ketones (specifically beta-hydroxybutyrate) designed to provide an alternative fuel source to the brain. By restoring metabolic balance, KetoSwiss aims to reduce the frequency and severity of migraine attacks without the side effects typical of pharmaceutical preventatives. The company is also exploring the application of its ketogenic formulations for other indications, including cognitive decline and Alzheimer's disease.